Spire Healthcare Group (LON:SPI) had its price objective reduced by Berenberg Bank from GBX 310 ($4.44) to GBX 290 ($4.15) in a research note issued to investors on Thursday, March 22nd. Berenberg Bank currently has a buy rating on the stock.
SPI has been the topic of a number of other reports. JPMorgan Chase reaffirmed a neutral rating and set a GBX 339 ($4.85) price objective on shares of Spire Healthcare Group in a report on Thursday, January 4th. Numis Securities raised shares of Spire Healthcare Group to a buy rating and set a GBX 296 ($4.24) price objective on the stock in a report on Friday, March 2nd. Jefferies Group raised shares of Spire Healthcare Group to a buy rating and lifted their price objective for the stock from GBX 259 ($3.71) to GBX 290 ($4.15) in a report on Wednesday, January 17th. Liberum Capital reaffirmed a hold rating and set a GBX 270 ($3.87) price objective on shares of Spire Healthcare Group in a report on Tuesday, January 16th. Finally, Barclays cut their price objective on shares of Spire Healthcare Group from GBX 270 ($3.87) to GBX 255 ($3.65) and set an equal weight rating on the stock in a report on Monday, March 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. Spire Healthcare Group has a consensus rating of Hold and a consensus target price of GBX 283.17 ($4.05).
LON:SPI traded up GBX 4 ($0.06) during mid-day trading on Thursday, hitting GBX 234.60 ($3.36). 873,474 shares of the company’s stock were exchanged, compared to its average volume of 1,770,000. Spire Healthcare Group has a fifty-two week low of GBX 206.40 ($2.96) and a fifty-two week high of GBX 362.10 ($5.18).
The business also recently declared a dividend, which will be paid on Tuesday, June 26th. Investors of record on Thursday, May 31st will be issued a GBX 2.50 ($0.04) dividend. This is an increase from Spire Healthcare Group’s previous dividend of $1.30. This represents a dividend yield of 1.12%. The ex-dividend date of this dividend is Thursday, May 31st.
In other news, insider Justin Ash acquired 46,500 shares of the stock in a transaction that occurred on Tuesday, March 6th. The shares were acquired at an average cost of GBX 215 ($3.08) per share, for a total transaction of £99,975 ($143,148.63).
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgeries, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat problems; and eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart diseases, and kidney disorders.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.